A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
Vision researchers at Columbia University Medical Center have discovered a gene that causes myopia, but only in people who spend a lot of time in childhood reading or doing other “nearwork.”
An automated speech analysis program correctly differentiated between at-risk young people who developed psychosis over a two-and-a-half year period and those who did not.
Klinefelter syndrome is the most common disorder of the male sex chromosomes, yet is rarely diagnosed in children. A new assessment tool is being developed by researchers at Columbia to help pediatricians detect the physical traits of the syndrome.
Biogen, the ALS Association, and Columbia University Medical Center have announced a new collaboration to better understand the differences and commonalities in the ALS disease process and how genes influence the clinical features of the disease.
A unique summer program, now in its 14th year, strives to attract more diversity to ranks of biomedical scientists. Two alumni of the program are currently studying at Columbia
Columbia researchers show through mouse models that a pharmaceutical agent may have value as a prophylactic against stress-induced psychiatric disorders.
Despite concerns that use of antipsychotic medications in treating young people has increased, use actually declined between 2006 and 2010 for children ages 12 and under, and increased for adolescents and young adults.
Children who are given prescription acid-reducing medications face a higher risk of developing C. diff. infection, a potentially severe colonic disorder.